Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains

Area of Science:

• Molecular Biology
• Cellular Signaling
• Oncology

Background:

• Ras proteins are key regulators of cell growth and differentiation, cycling between GDP-bound (inactive) and GTP-bound (active) states.
• Oncogenic mutations in Ras lead to aberrant activity, driving cell transformation, tumor growth, and progression.

Purpose of the Study:

• To develop a novel strategy to inhibit deregulated Ras activity.
• To create a tool for selective blockade of oncogenic Ras signals.

Main Methods:

• Oligomerized protein modules derived from the Ras-binding domain of c-Raf (RBD) were engineered, named MSOR (multivalent scavengers of oncogenic Ras).
• Mutations were introduced into RBD to modulate affinity and blocking potency against activated Ras.
• An inducible MSOR-expression system was developed for controllable reversal of oncogenic Ras effects.

Main Results:

• MSOR effectively inhibited oncogenic Ras-stimulated processes, including Erk1/2 activation, matrix-degrading enzyme induction, cell motility, and invasiveness.
• Inhibition occurred in a graded manner, dependent on MSOR's oligomerization grade and individual RBD-module composition.
• The inducible system allowed for controllable reversal of oncogenic Ras effects.

Conclusions:

• MSOR represents a novel class of molecules for targeting oncogenic Ras.
• These findings provide a new tool for experimental investigation of Ras signaling.
• MSOR holds potential for selective blockade of oncogenic Ras in therapeutic applications.